Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 9INDUSTRY 8INDIV 2

Study Type

Interventional 2

Sponsor

Conditions

Lipoma 2

Interventions

Proflavine 9pembrolizumab 2Tacrolimus 2Pyridostigmine Bromide 2Prednisone 2Microbial Collagenase 2sargramostim 1plerixafor 1pegfilgrastim 1olaparib 1nilotinib 1macimorelin 1keyhole-limpet hemocyanin 1ethyl pyruvate 1compound W 1blinatumomab 1Watchful Waiting 1Uracil 1Tegafur 1Surgical Procedures, Operative 1Steroids 1Sodium Chloride 1Sirolimus 1Salicylates 1Peptides 1PM 01183 1Mycophenolic Acid 1Monatide (IMS 3015) 1Mifepristone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDIV × Microbial Collagenase × Clear all
NCT02249052 2017-02-23

Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma

Gerut, Zachary, M.D.

Phase 2 Completed
19 enrolled 11 charts

Lipoma

NCT01613313 2016-10-06

A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma

Gerut, Zachary, M.D.

Phase 2 Completed
14 enrolled 8 charts

Lipoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡